As a global organisation that spans the whole spectrum of data analysis within healthcare, PHUSE features in the news for its ongoing work with regulators, industry partners and other professionals who are passionate about advancing clinical information.
Take a look below to find out more and email communications@phuse.global for any press or media enquiries.
For the most up to date PHUSE News, please see our blogs.
10th
November
2020
We are now making available a data synthesis platform, as part of the PHUSE Open Data Repository (PODR), in partnership with Replica Analytics Ltd. This is available free for non-commercial purposes and allows users to gain first-hand experience with data synthesis.
6th
July
2020
PHUSE announces the availability of the PHUSE Open Data Repository (“PODR”) built on Microsoft Azure. PODR includes Open Data from the European Union (European Medicines Agency); the U.S. (FDA, HHS, National Library of Medicine; Medicare; USA Spending); and the World Health Organization (clinical trials).
9th
June
2019
PHUSE, an independent membership society and non-profit organisation created by volunteers who work in the pharmaceutical industry, announced today that it has successfully transitioned two guidance papers from TransCelerate BioPharma Inc. under its umbrella. These guidance documents address clinical data transparency and the de-identification and anonymisation concerning individual patient data. As part of this transition, PHUSE is responsible for future updates to the guidance documents.
17th
April
2018
PHUSE is excited to announce a brand-new think tank for pharmaceutical thought leaders. Running alongside PHUSE’s first-ever US Connect conference, in Raleigh, North Carolina, June 3-6 2018, the PHUSE Executive Summit is an industry first.
1st
December
2016
PHUSE, the biggest membership driven community of clinical data scientists, organises its first multi-day annual US conference to take place in Raleigh, NC in Summer 2018.
22nd
November
2016
The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) is establishing a public docket to collect comments related to a proposed Study Data Standardisation Plan (SDSP) template. As part of the FDA’s on going collaboration with PHUSE, an independent, non-profit consortium addressing computational science issues, the SDSP template was developed by a PHUSE computational science working group.
7th
March
2016
The Food and Drug Administration (FDA) publishes intent to review the PHUSE Nonclinical SDRG for regulatory submissions, which has been developed by PHUSE Computational Sciences working groups.
4th
August
2015
The PMDA has released English versions of technical notifications which require drug makers to submit their electronic data in CDISC-standard format and using SDRGs and ADRGs developed by PHUSE working groups.
